PL412005A1 - Water-soluble intelligent gold complexes (III) and application of water-soluble, intelligent gold complexes (III) - Google Patents

Water-soluble intelligent gold complexes (III) and application of water-soluble, intelligent gold complexes (III)

Info

Publication number
PL412005A1
PL412005A1 PL412005A PL41200515A PL412005A1 PL 412005 A1 PL412005 A1 PL 412005A1 PL 412005 A PL412005 A PL 412005A PL 41200515 A PL41200515 A PL 41200515A PL 412005 A1 PL412005 A1 PL 412005A1
Authority
PL
Poland
Prior art keywords
soluble
iii
water
gold complexes
intelligent
Prior art date
Application number
PL412005A
Other languages
Polish (pl)
Other versions
PL232677B1 (en
Inventor
Stanisław Szczepaniak
Remigiusz Szczepaniak
Dominika Szczepaniak
Monika Szczepaniak
Elwira Szczepaniak
Original Assignee
Stanisław Szczepaniak
Remigiusz Szczepaniak
Dominika Szczepaniak
Monika Szczepaniak
Elwira Szczepaniak
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanisław Szczepaniak, Remigiusz Szczepaniak, Dominika Szczepaniak, Monika Szczepaniak, Elwira Szczepaniak filed Critical Stanisław Szczepaniak
Priority to PL412005A priority Critical patent/PL232677B1/en
Publication of PL412005A1 publication Critical patent/PL412005A1/en
Publication of PL232677B1 publication Critical patent/PL232677B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Ujawniono wodorozpuszczalne, inteligentne kompleksy złota (III) o ogólnym wzorze 1: [Au(CN)m]n(m-p)n ,gdzie m ma wartość od 3 do 6, n ma wartość od 1 do 10, p ma wartość od 1 do 3. Zastosowanie wodorozpuszczalnych, inteligentnych kompleksów złota (III) o wzorze ogólnym 1 w postaci pojedynczego leku lub środka farmaceutycznego, lub suplementu diety, lub dodatku do żywności w terapeutycznie uzasadnionej ilości i dowolnym sposobie podawania.Water-soluble intelligent gold (III) complexes with general formula 1 are disclosed: [Au (CN) m] n (mp) n, where m is from 3 to 6, n is from 1 to 10, p is from 1 to 10 3. Use of water-soluble intelligent gold (III) complexes of general formula 1 in the form of a single drug or pharmaceutical agent, or dietary supplement, or food additive in a therapeutically justified amount and in any method of administration.

PL412005A 2015-04-15 2015-04-15 Water-soluble intelligent gold complexes (III) and application of water-soluble, intelligent gold complexes (III) PL232677B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL412005A PL232677B1 (en) 2015-04-15 2015-04-15 Water-soluble intelligent gold complexes (III) and application of water-soluble, intelligent gold complexes (III)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL412005A PL232677B1 (en) 2015-04-15 2015-04-15 Water-soluble intelligent gold complexes (III) and application of water-soluble, intelligent gold complexes (III)

Publications (2)

Publication Number Publication Date
PL412005A1 true PL412005A1 (en) 2016-10-24
PL232677B1 PL232677B1 (en) 2019-07-31

Family

ID=57821648

Family Applications (1)

Application Number Title Priority Date Filing Date
PL412005A PL232677B1 (en) 2015-04-15 2015-04-15 Water-soluble intelligent gold complexes (III) and application of water-soluble, intelligent gold complexes (III)

Country Status (1)

Country Link
PL (1) PL232677B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019008013A1 (en) 2017-07-04 2019-01-10 Szczepaniak Stanislaw Water-soluble gold (iii) complexes, methods of producing water-soluble gold (iii) complexes and their use

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019008013A1 (en) 2017-07-04 2019-01-10 Szczepaniak Stanislaw Water-soluble gold (iii) complexes, methods of producing water-soluble gold (iii) complexes and their use
PL422125A1 (en) * 2017-07-04 2019-01-14 Stanisław Szczepaniak Water-soluble intelligent gold complexes (III), method for producing water-soluble intelligent gold complexes (III) and their application

Also Published As

Publication number Publication date
PL232677B1 (en) 2019-07-31

Similar Documents

Publication Publication Date Title
MY192084A (en) Pyrazolo-heteroaryl derivative, preparation method and medical use thereof
MY195180A (en) Anti-HER3 Antibody-Drug Conjugate
PH12018501956A1 (en) 3-desoxy derivative and pharmaceutical compositions thereof
PH12019501811A1 (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
EA201691918A1 (en) PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE
SA522431304B1 (en) Preparation of lasmiditan and its acetate salt
PH12017500481A1 (en) Novel soluble guanylate cyclase activators and their use
EP3318282A4 (en) DRUG DELIVERY VECTOR, AND COMPOSITION CONTAINING THE SAME
JOP20200004B1 (en) Long-acting formulations
PH12020500074A1 (en) Peptide
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
NZ752214A (en) Arsenic compositions
PL412005A1 (en) Water-soluble intelligent gold complexes (III) and application of water-soluble, intelligent gold complexes (III)
MX2015017446A (en) New macrocyclic amidinourea derivatives, methods of preparation and uses thereof as chitinase inhibitors.
MX2015017881A (en) Method for preventing and/or treating chronic traumatic encephalopathy-ii.
UA114840C2 (en) ANTI-TUMOR AGENT INCLUDING IRINOTECAN HYDROCHLORIDE HYDRAUL
GEP20196957B (en) Crystalline forms of s-acetyl glutathione, their reparations and uses in pharmaceutical and nutraceutical formulations
PL436978A1 (en) Use of water-soluble gold (III) complexes
PL428118A1 (en) Complex organic silicon compounds, method of preparing complex organic silicon compounds and use of complex organic silicon compounds
RU2014107146A (en) METHOD FOR PREVENTING A CARCINOGENIC EFFECT OF DIETHYLNITROSAMINE IN EXPERIMENTAL ANIMALS
PL409503A1 (en) Dietary supplement and therapeutic mixture
UA120079C2 (en) APPLICATION OF 2-SUBSTITUTED 5-ARYLSULPHONYL-1,3-OXAZOLE-4-CARBONITRILLES AS ANTI-CANCER DRUGS
Yiyi President Li Xiaolin Leads CPAFFC Delegation to Thailand
PL425238A1 (en) Application of 2'-hydroxy-4-ethylchalcone
PL425239A1 (en) Application of 2'-hydroxy-4-methylchalcone